FDA Pushes Back Decision on Sotorasib/Panitumumab in Colorectal Cancer
The FDA was expected to decide on the application of sotorasib and panitumumab for the treatment of metastatic colorectal cancer on October 17, 2024.
The FDA was expected to decide on the application of sotorasib and panitumumab for the treatment of metastatic colorectal cancer on October 17, 2024.
Eric Kumar Singhi, MD, discusses the current therapeutic landscape and unmet needs in small cell and non–small cell lung cancer.
Acute Myeloid Leukemia is a type of blood cancer that occurs in the blood and bone marrow.
Rates of treatment-related adverse events were similar between the treatment arms.
Mark Ronson performs Nothing Breaks Like A Heart ft Miley Cyrus in the BBC Radio 1 Live Loungehttp://vevo.ly/c6hCVY#MarkRonson #NothingBreaksLikeAHeart #Vevo…
The 12th International Workshop on Waldenstrom’s Macroglobulinemia (IWWM-12) took place in Prague, Czech Republic. This meeting brought together leading experts to discuss the latest advances…
Britain’s departure from the European Union cost London’s financial centre about 40,000 jobs, the Lord Mayor of the City of London told Reuters, a far…
“Treatment effectiveness can have different meanings to patients,” a physician assistant said when discussing therapy for high-risk myeloma.
During a Case-Based Roundtable® event, Ursa Brown-Glaberman, MD, discussed options for the treatment of patients with PIK3CA-altered metastatic breast cancer.
Among the major dilemmas persisting in CAR-T therapy use is how to balance malignancy risks.
Explore some of the interesting terms used in cancer research and data science, and get tips on how you can make sure you’re communicating effectively!